This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Japan, Tokyo


The the headquarters of this Corporate Investor is in Tokyo. This investor is located in Asia, Japan.

Typical investments for this fund are deals in the range of 10 - 50 millions dollars. The fund generally invests in less than 2 deals every year. In 2013, the fund's activity was at its peak. The most exits for the fund occurred in 2015.

The country of its foundation and the country of the most frequent investments for the fund coincides - Japan. Also, a start-up has to be aged 2-3 years to expect investment from this fund. Healios K.K is among the most popular portfolio start-up of the fund. Among their most successful investment fields, we have identified Biotechnology, Health Care. Also, because of its portfolio diversification tendency, we can highlight 1 more industry for this fund.

The fund usually invests in rounds together with 5 others. Along with tella, start-ups are often financed by Nomura. Other VCs who often invest in the same rounds are Shin Nippon Biomedical Laboratories (SNBL), Nikon, Dainippon Sumitomo Pharma.

Fund Activity

Not operative

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing in Previous


If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: